Site and disease selection for hyperthermia clinical trials

Area of Science:

• Oncology
• Biophysics
• Medical Physics

Background:

• Significant advancements in understanding hyperthermia's biological effects and related technologies over the last two decades.
• Uncontrolled studies suggest hyperthermia combined with radiation or chemotherapy improves local cancer control with acceptable toxicity.
• Need for well-controlled, site-specific trials to validate hyperthermia's efficacy in cancer treatment.

Purpose of the Study:

• To review progress in hyperthermia research and technology.
• To emphasize the necessity of prospective randomized trials for establishing hyperthermia's role in oncology.
• To explore criteria for selecting tumor sites for future clinical trials.

Main Methods:

• Review of biological mechanisms of hyperthermia-induced cytotoxicity and thermoenhancement.
• Assessment of technological developments in hyperthermia delivery (microwave, radiofrequency, ultrasound) and thermometry.
• Discussion of trial design considerations, including standardization, thermometry, and endpoint selection.

Main Results:

• Progress in understanding hyperthermia's effects on cancer cells and its synergistic potential with conventional therapies.
• Development of clinically applicable equipment for hyperthermia treatment and monitoring.
• Evidence from uncontrolled trials indicating potential for improved local tumor control.

Conclusions:

• Hyperthermia holds significant promise as an adjunct cancer therapy.
• Standardized, well-controlled clinical trials are crucial to definitively establish hyperthermia's role and optimize its application.
• Careful selection of tumor sites suitable for current hyperthermia technology is essential for successful trials and patient benefit.